Table 1 of Abu-Amero, Mol Vis 2008; 14:518-522. Table 1 of Abu-Amero, Mol Vis 2008; 14:518-522.
Table 1. Haplogroup distribution in glaucoma patients and controls.
| Mitochondrial haplogroup | Controls (n=552) | Glaucoma patients (n=107) | Odds ratio | 95% C.I. | p-Value |
| H | 47 (8.5%) | 7 (6.5%) | 0.75 | 0.30–1.79 | 0.62 |
| I | 5 (0.9%) | 1 (0.9%) | 1.03 | 0.17–6.20 | 1 |
| J | 116 (21%) | 22 (20.6%) | 0.97 | 0.56–1.67 | 0.98 |
| K | 22 (4%) | 4 (3.7%) | 0.94 | 0.27–2.95 | 1 |
| L0 | 6 (1.1%) | 1 (0.9%) | 0.86 | 0.14–5.44 | 1 |
| L1 | 3 (0.5%) | 2 (1.9%) | 3.49 | 0.40–25.9 | 0.19 |
| L2 | 20 (3.6%) | 6 (5.6%) | 1.58 | 0.555–4.29 | 0.41 |
| L3 | 22 (4%) | 5 (4.7%) | 1.18 | 0.38–3.39 | 0.79 |
| L4 | 1 (0.2%) | 2 (1.9%) | 10.5 | 0.74–294.9 | 0.07 |
| L5 | 4 (0.7%) | 2 (1.9%) | 2.61 | 0.33–16.70 | 0.25 |
| M | 17 (3.1%) | 0 | 0.15 | 0.009–2.46 | 0.09 |
| M1 | 19 (3.5%) | 6 (5.6%) | 1.67 | 0.58–4.56 | 0.27 |
| N | 41 (7.4%) | 1 (0.9%) | 0.12 | 0.01–0.81 | 0.02 |
| preHV1 | 99 (17.9%) | 31 (29%) | 1.87 | 1.13–3.06 | 0.0127 |
| R | 17 (3.1%) | 0 | 0.15 | 0.009–2.46 | 0.09 |
| T | 34 (6.2%) | 4 (3.7%) | 0.59 | 0.17–1.80 | 0.45 |
| U | 58 (10.5%) | 10 (9.4%) | 0.88 | 0.41–1.85 | 0.85 |
| W | 6 (1.1%) | 0 | 0.425 | 0.024–7.67 | 0.59 |
| X | 15 (2.7%) | 3 (2.8%) | 1.03 | 0.23–3.88 | 1.0 |